Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Strategies for Diarrhea/Constipation Hydration: Essential for managing both conditions
Johns EJ, Kopp UC, DiBona GF
Research applications In-vitro modeling of synergistic GHRH/GHRP receptor cross-talk Pre-clinical study of pulsatile GH-secretagogue dynamics Comparative receptor-pathway research (cAMP vs calcium convergence) Reference standard for analytical characterization of blended preparations Key facts Combines a GHRH-receptor analog with a selective GHS-R1a agonist Nominal 5mg + 5mg per-component loading per vial Components act through mechanistically independent, convergent pathways Supplied as a co-lyophilized research powder for in-vitro use Product specifications Class: GHRH analog + GHRP/ghrelin-receptor agonist research blend Also known as: Mod-GRF + Ipamorelin blend Form: Lyophilized powder vial Purity: 99% (HPLC verified) Testing: Independent third-party HPLC + mass spectrometry Documentation: Certificate of analysis per batch Storage: Store lyophilized at -20C
Supplements Supporting Metabolism and Gut Health metabolism, appetite management, and healthy blood sugar levels using natural botanical extracts and nutrients
Elam RE, Buzkova P, Barzilay JI, Wang Z, Nemet I, Budoff MJ, Cauley JA, Fink HA, Lee Y, Robbins JA et al
For example, the lowest dose studied and approved for Zepbound (tirzepatide) is 2.5 mg
US$ 21.01
US$ 22.68
US$ 29.00
US$ 21.34
US$ 20.60
US$ 22.73
US$ 22.36
US$ 25.95
US$ 23.20
US$ 23.42
US$ 23.83
US$ 22.33
US$ 25.50
US$ 26.61
